# PT-141 (bremelanotide) side effects: phase 3 safety data

Source: https://pepvault.app/research/pt-141-clayton-2022

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [PT-141](https://pepvault.app/research#pt-141)

Systematic review · people

# PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data

Checked against the paper November 2026 Systematic review [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

Nausea is the side effect most likely to show up on bremelanotide and the main reason people quit; blood pressure bumps were small and brief, and the authors advise care for people at risk of heart disease.

- **Kind:** Systematic review
- **Studied in:** People
- **Number studied:** 3500
- **Published:** 2022
- **Journal:** J Womens Health (Larchmt)

## What they tested

The team set out to describe the side effects and safety of bremelanotide across its whole clinical program, from phase 1 through phase 3.

## How the study was done

A review of safety data from 43 completed studies with 3500 people, including a pooled look at the double-blind, placebo-controlled part of the phase 3 studies in 1247 people. In phase 3, people used bremelanotide for up to 18 months.

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In the pooled phase 3 data, nausea was the most common side effect (40.0% on bremelanotide vs 1.3% on placebo, a dummy shot), followed by flushing (20.3% vs 1.3%), headache (11.3% vs 1.9%) and injection site reactions (5.4 vs 0.5). Nausea was the top reason people stopped the drug, and 70% of the bremelanotide group moved on to the open-label phase vs 87% of the placebo group. No one died, and a few people had serious side effects. Patches of darkened skin were rare at label dosing but showed up in more than one-third of people given up to 16 daily doses in a row, and blood pressure rose slightly for a short time during ambulatory monitoring, meaning readings taken as people went about their day.

## What it doesn’t show

This is a safety review, so it does not show how well the drug works. The darkened skin result came from daily dosing outside the label schedule, and the long-term data reach only 18 months.

## The paper

Clayton et al. Safety Profile of Bremelanotide Across the Clinical Development Program. J Womens Health (Larchmt). 2022.

- [PubMed (PMID 35147466)](https://pubmed.ncbi.nlm.nih.gov/35147466/)
- [The paper (DOI 10.1089/jwh.2021.0191)](https://doi.org/10.1089/jwh.2021.0191)
- [ClinicalTrials.gov (NCT02333071)](https://clinicaltrials.gov/study/NCT02333071)

## The compound

- [PT-141: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

## With this study

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016)
- [All 3 studies](https://pepvault.app/research#pt-141)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on PT-141

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021) Meta-analysis · people · 2021
- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016) Randomized trial · people · 2016
- [Every study on PT-141](https://pepvault.app/research#pt-141)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016)
- [All 3 studies](https://pepvault.app/research#pt-141)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on PT-141](https://pepvault.app/research#pt-141)

## The library

- [PT-141](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
